1. Home
  2. > Pharmaceutical
  3. > Drug Development Market Trends
Global eClinical solutions Market Size, Share & Industry Trends Analysis Report By Delivery Mode, By Product, By Clinical Trials Phase, By End User, By Regional Outlook and Forecast, 2022 - 2028

Global eClinical solutions Market Size, Share & Industry Trends Analysis Report By Delivery Mode, By Product, By Clinical Trials Phase, By End User, By Regional Outlook and Forecast, 2022 - 2028

  • August 2022
  • 318 pages
  • ID: 6321960
  • Format: PDF
  • KBV Research

Summary

Table of Contents

The Global eClinical solutions Market size is expected to reach $20.1 billion by 2028, rising at a market growth of 13.6% CAGR during the forecast period.

With professional data services as well as the elluminate Clinical Data Cloud, eClinical Solutions assists life sciences enterprises all over the world in accelerating clinical development projects. The elluminate platform and digital data services provide clients with self-service access to all of their data from a single, central location, as well as comprehensive analytics that aid in the faster and more informed decision-making process for businesses.

For the effective administration of data for clinical trials, a variety of eClinical solutions are employed, that includes electronic data capture & clinical data management systems, randomization and trial supply management, clinical trial management systems, and others. It aids in the efficient integration and management of data produced during clinical studies.

It provides a suite of tools to efficiently organize, manage, track, and create insights for clinical research portfolios. It integrates contact management sites and teams, a calendar and monitoring system, and document management. As a result, it creates approved clinical research outcomes as well as compliant submissions; stores and regulates data entry; authenticates the reliability and integrity of the data, and makes it possible to improve the patient experiences by accelerating drug development.

Covid-19 Impact Analysis

The market for eClinical solutions is expected to benefit from the COVID-19 pandemic. To expand hospital capacity for patients diagnosed with COVID-19, a significant number of clinics and hospitals around the world underwent restructuring. A potential backlog in non-essential procedures developed as a result of the sharp increase in COVID-19 cases. The lockdown caused delays in the production and delivery of critical medical supplies.

Market Growth Factors

Operational Expenditures and Regulatory Needs are rising

Customized or gene-based disease management is becoming more popular in the field of medical research and innovative drug treatments. In comparison to presently available alternative therapies or medications, government reimbursement organizations, commercial insurers, and payers frequently demand novel drugs that have a better therapeutic value and greater efficacy. Additionally, by controlling the standard pricing of innovative pharmaceuticals, these payers are reducing manufacturing businesses’ profit margins. The eClinical solutions market is concentrating on the development and marketing of software solutions that help speed up and efficiently complete clinical studies.

Rising Adoption of Software Solutions in Clinical Trails

Due to the growing amount of data produced throughout clinical development processes, there is an increased need for recording and analyzing clinical data, which has led to a growth in the use of eClinical solutions in clinical trials. Furthermore, eClinical technologies improve site performance, clinical trial efficiency, and cost optimization by removing redundant data entry. Also, it is noted that the rapid uptake of eClinical solutions, such as RTSM, combined with effective trial drug supply management, would motivate key companies to increase their investment for product innovations.

Market restraining Factors

High Cost of Implementation

In order to efficiently manage the clinical research data and information throughout the research lifecycle, researchers might use eClinical solutions. Many integrated eClinical solutions (like CTMS and CDMS) offer clinical researchers end-to-end solutions for all phases of clinical trial administration. These software solutions are, quite costly and charged at a premium rate. With additional costs for technical support cloud-based systems, the installation, and maintenance of eClinical solutions.

Delivery Mode Outlook

Based on delivery mode, the eClinical solution market is segmented into web-based (on-demand) model, licensed enterprise (on-premise) model, and cloud-based (SaaS) model. The cloud-based (SaaS) segment acquired a substantial revenue share in the eClinical solution market in 2021. This is due to integrated features including flexibility, high accessibility, minimal handling costs, and simple data backup. These systems make real-time data available, allowing users to act quickly and give high-quality data for risk-based monitoring.

Clinical Trial Phase Outlook

On the basis of the clinical trial phase, the eClinical solution market is fragmented into phase I, phase II, phase III, and phase IV. In 2021, the phase III segment led the eClinical solutions market with the highest revenue share. The segment is expanding as a result of the increasing need for clinical data management software to reduce overall costs and boost process effectiveness. The expansion of the market is being significantly accelerated by the rising number of medications that successfully complete phase III.

Product Outlook

By product, the eClinical solution market is categorized into CDMS/EDC Solutions, CTMS Solutions, analytics & reporting platforms, safety solutions, integration platforms, RTMS solutions, eCOA solutions and others. The CTMS solutions segment generated a significant revenue share in the eClinical solutions market in 2021. In order to manage clinical trials for clinical research, the biotechnology & pharmaceutical industries use a clinical trial management system (CTMS). These are employed in clinical research to manage clinical trials. This CTMS will support clinical research carried out within or among the three institutions as a single, centralized, web-based enterprise resource.

End User Outlook

Based on the end user, the eClinical solution market is classified into pharmaceutical & biopharmaceutical companies, contract research organizations, academic research institutions, hospitals, medical device manufacturers, and others. The pharmaceutical & biopharmaceutical companies held the highest revenue share in the eClinical solution market in 2021. Companies in the biotechnology and pharmaceutical industries can locate clinical trial-related administrative obstacles by using such software solutions. Researchers at pharmaceutical and biotechnology companies are subsequently driving the demand for eClinical solutions for clinical research programs.

Regional Outlook

Region wise, the eClinical solution market is analyzed across North America, Europe, Asia Pacific, and LAMEA. In 2021, the North America region witnessed the largest revenue share in the eClinical solutions market. The regional growth is the result of its established business infrastructure, cutting-edge technology, and accessibility of key players. The demand for eClinical solutions in this region is rising as a result of increased government regulations to support clinical trials, ongoing product improvements and new product launches by major players in the eClinical solution market, and a rise in the number of collaborations for innovative drug development.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Oracle Corporation, Anju Software, Inc., eClinical Solutions LLC, Castor EDC, Signant Health, Dassault Systemes SE, Parexel International Corporation (Phoenix Parentco, Inc.), Clario, BSI Life Sciences (Business Systems Integration AG) and MedNet Solutions

Strategies Deployed in eClinical solutions Market

May-2022: Signant Health released Oncology Complete, a new solution bundle to address specific challenges and evolving needs in oncology clinical research. By this launch, the company would offer a new solution bundle to meet specific challenges and emerging requirements in oncology clinical research. Oncology Complete single-source allows sponsors to conduct simple as well as complicated trials efficiently and cost-effectively.

Mar-2022: BSI teamed up with CloudScientific Technology, Shanghai-based pharma IT distributor. This collaboration would help the company to acquire new consumers and also let more prospects know about BSI’s CTMS and eTMF and their great potential to accelerate the time to market drugs & medical devices.

Dec-2021: Oracle Corporation acquired Cerner Corporation, an American supplier of health information technology services, devices, and hardware. This acquisition aimed to assist Oracle to scale up its cloud business in the hospital and health system market.

Nov-2021: eClinical Solutions expanded their existing product elluminate by adding Risk-Based Quality Management (RBQM) offering. The expansion would provide a renewed approach to risk-based quality management which enable active oversight along with ensuring study data integrity from start to finish.

Jul-2021: Castor entered into a partnership with Lightship, a company providing direct-to-patient clinical trial solutions. This partnership would enable combining Lightship’s operational excellence in clinical studies and technology that delivers for the most complex clinical trials.

Sep-2020: Castor partnered with Click Therapeutics, a leader in the field of digital therapeutics. The partnership focused on providing solutions for conducting fully remote clinical trials.

Jun-2020: Oracle Health Sciences launched Clinical One Data Collection Cloud Service. The company focused on delivering on this promise by providing the industry with a unified platform that supports companies’ requirements. Clinical One Data Collection would support event-based data collection and would streamline workflow, providing the consumers with the agility and cost savings they require to get therapies to market faster.

Oct-2019: Oracle Health Sciences collaborated with Phlexglobal, a pioneer in the provision of Trial Master File (TMF) technology and services. This launch aimed at accelerating the speed as well as the accuracy of regulatory compliance & inspection readiness in clinical trials.

Sep-2019: Anju Software took over OmniComm Systems, a healthcare technology company. This acquisition aimed to position the company as the fastest-growing provider in the eClinical arena, and the complementary products of both companies form a truly comprehensive eClinical suite.

Oct-2018: Oracle signed an agreement to acquire goBalto, a software platform that develops cloud-based solutions for drug trial sponsors. The acquisition aimed to enable the consumers to remove another barrier to delivering treatments to patients faster. Through this acquisition, the company would be able to provide the most complete end-to-end cloud platform dedicated to unifying action & accelerating results for the Life Sciences industry.

Scope of the Study

Market Segments covered in the Report:

By Delivery Mode

• Web-based (on-demand) Model

• Licensed enterprise (on-premise) Model

• Cloud-based (saas) Model

By Product

• CDMS/EDC Solutions

• CTMS Solutions

• Analytics & Reporting Platforms

• Safety Solutions

• Integration Platforms

• RTMS Solutions

• eCOA Solutions

• Others

By Clinical Trials Phase

• Phase III

• Phase II

• Phase IV

• Phase I

By End User

• Pharmaceutical & Biopharmaceutical Companies

• Academic Research Institutions

• Hospitals

• Contract Research Organizations

• Medical Device Manufacturers

• Others

By Geography

• North America

o US

o Canada

o Mexico

o Rest of North America

• Europe

o Germany

o UK

o France

o Russia

o Spain

o Italy

o Rest of Europe

• Asia Pacific

o China

o Japan

o India

o South Korea

o Singapore

o Malaysia

o Rest of Asia Pacific

• LAMEA

o Brazil

o Argentina

o UAE

o Saudi Arabia

o South Africa

o Nigeria

o Rest of LAMEA

Companies Profiled

• Oracle Corporation

• Anju Software, Inc.

• eClinical Solutions LLC

• Castor EDC

• Signant Health

• Dassault Systemes SE

• Parexel International Corporation (Phoenix Parentco, Inc.)

• Clario

• BSI Life Sciences (Business Systems Integration AG)

• MedNet Solutions

Unique Offerings

• Exhaustive coverage

• Highest number of market tables and figures

• Subscription based model available

• Guaranteed best price

• Assured post sales research support with 10% customization free

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 150+ Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
  • Single User License — provides access to the report by one individual.
  • Department License — allows you to share the report with up to 5 users
  • Site License — allows the report to be shared amongst all employees in a defined country
  • Corporate License — allows for complete access, globally.

ReportLinker may already be registered as a supplier with your company. If you want to Order by PO, check with us first and we'll let you know if we are a registered supplier and what the vendor number is. Otherwise, we'll provide you with the necessary information to register ReportLinker as a vendor.

Grace helps you find the right report:
Testimonials

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

We were impressed with the support that ReportLinker’s research specialists’ team provided. The report we purchased was useful and provided exactly what we want.

Category Manager at
Ikea

ReportLinker gave access to reliable and useful data while avoiding dispersing resources and spending too much time on unnecessary research.

Executive Director at
PwC Advisory

The customer service was fast, responsive, and 100% professional in all my dealings (...) If we have more research needs, I'll certainly prioritize working with ReportLinker!

Scott Griffith

Vice President Marketing at
Maurice Sporting Goods

The research specialist provided prompt, helpful instructions for accessing ReportLinker's product. He also followed up to make sure everything went smoothly and to ensure an easy transition to the next stage of my research

Jessica P Huffman

Research Associate at
American Transportation Research Institute

Excellent customer service. Very responsive and fast.

Director, Corporate Strategy at
Ingredion

I reached out to ReportLinker for a detailed market study on the Air Treatment industry. The quality of the report, the research specialist’s willingness to solve my queries exceeded my expectations. I would definitely recommend ReportLinker for in-depth industry information.

Mariana Mendoza

Global Platform Senior Manager at
Whirlpool Corporation

Thanks! I like what you've provided and will certainly come back if I need to do further research works.

Bee Hin Png

CEO at
LDR Pte Ltd

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

FAQ
  • How we can help
    • I am not sure if the report I am interested in will fulfill my needs. Can you help me?
    • Yes, of course. You can call us at +33(0) 4 37 65 17 03 or drop us an email at [email protected] to let us know more about your requirements.
    • We buy reports often - can ReportLinker get me any benefits?
    • Yes. Set up a call with a Senior Research Advisor to learn more - [email protected] or +33(0) 4 37 65 17 03.
    • I have had negative experiences with market research reports before. How can you avoid this from happening again?
    • We advise all clients to read the TOC and Summary and list your questions so that we can get more insight for you before you make any purchase decision. A research advisor will accompany you so that you can compare samples and reports from different sources, and choose the study that is right for you.

  • Report Delivery
    • How and when I will receive my Report?
    • Most reports are delivered right away in a pdf format, while others are accessed via a secure link and access codes. Do note that sometimes reports are sent within a 12 hour period, depending on the time zones. However, you can contact us to escalate this. Should you need a hard copy, you can check if this option is offered for the particular report, and pay the related fees.
  • Payment conditions
    • What payment methods do you accept?
      1. Credit card : VISA, American Express, Mastercard, or
      2. You can download an invoice to pay by wire transfer, check, or via a Purchase Order from your company, or
      3. You can pay via a Check made out in US Dollars, Euros, or British Pounds for the full amount made payable to ReportLinker
    • What are ReportLinker’s Payment Terms?
    • All payments must normally be submitted within 30 days. However, you can let us know if you need extended time.
    • Are Taxes and duties included?
    • All companies based in France must pay a 20% tax per report. The same applies to all individuals based in the EU. All EU companies must supply their VAT number when purchasing to avoid this charge.
    • I’m not satisfied. Can I be refunded?
    • No. Once your order has been processed and the publisher has received a notification to send you the report, we cannot issue any refund or cancel any order. As these are not ‘traditional’ products that can be returned, reports that are dispatched are considered to be ‘consumed’.
  • User license
    • The license that you should acquire depends on the number of persons that need to access the report. This can range from Single User (only one person will have the right to read or access the report), or Department License (up to 5 persons), to Site License (a group of persons based in the same company location), or Corporate License (the entire company personnel based worldwide). However, as publishers have different terms and conditions, we can look into this for you.
Purchase Reports From Reputable Market Research Publishers

Orthodontic Materials and Products Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2022 Update

  • $ 2500
  • December 2022
  • 116 pages

Orthodontic Materials and Products Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2022 Update Summary Medical Devices sector report, ...

  • World
  • United States
  • Clinical Trial
  • Company research
  • Company
  • Oral Surgeries
  • Medical Technology Density

ref:plp2022

Reportlinker.com © Copyright 2023. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.

Make sure you don’t miss any news and follow us on